Cargando…

Multiple sclerosis drug repurposing for neuroregeneration

Detalles Bibliográficos
Autores principales:	Göttle, Peter, Dietrich, Michael, Küry, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581586/ https://www.ncbi.nlm.nih.gov/pubmed/37721276 http://dx.doi.org/10.4103/1673-5374.380901

Ejemplares similares

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Optogenetic neuroregeneration
por: Janovjak, Harald, et al.
Publicado: (2021)

Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?
por: Göttle, Peter, et al.
Publicado: (2015)

Purinergic signalling in neuroregeneration
por: Burnstock, Geoffrey
Publicado: (2015)

Neuroregeneration using in vivo cellular reprogramming
por: Nguyen, Tu, et al.
Publicado: (2017)

The Molecular Basis for Remyelination Failure in Multiple Sclerosis
por: Gruchot, Joel, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs
por: Habtemariam, Solomon
Publicado: (2018)

Mitofusin activation enhances mitochondrial motility and promotes neuroregeneration in CMT2A
por: Dorn, Gerald W.
Publicado: (2021)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Contribution of purinergic receptors to spinal cord injury repair: stem cell-based neuroregeneration
por: Gomez-Villafuertes, Rosa
Publicado: (2016)

The innate immune system in Parkinson's disease: a novel target promoting endogenous neuroregeneration
por: Schlachetzki, Johannes CM, et al.
Publicado: (2015)

How does zebrafish support new strategies for neuroprotection and neuroregeneration in hypoxia-related diseases?
por: Silva, Emerson S., et al.
Publicado: (2016)

The roles of atypical protein kinase Cs (aPKCs) in the nervous system: targets for neuroregeneration?
por: Chau, Dennis Dik-Long, et al.
Publicado: (2020)

The Hsp90-binding immunophilin FKBP52 enhances neurodifferentiation and neuroregeneration in murine models
por: Daneri-Becerra, Cristina, et al.
Publicado: (2021)

Membrane progesterone receptors (mPRs/PAQRs) in Schwann cells represent a promising target for the promotion of neuroregeneration
por: Castelnovo, Luca F., et al.
Publicado: (2020)

Repurposing Histaminergic Drugs in Multiple Sclerosis
por: Amadio, Susanna, et al.
Publicado: (2022)

Aberrant Oligodendrogenesis in Down Syndrome: Shift in Gliogenesis?
por: Reiche, Laura, et al.
Publicado: (2019)

Neuroregeneration in neurodegenerative disorders
por: Enciu, Ana M, et al.
Publicado: (2011)

Neuroregeneration in the visual cortex
Publicado: (2012)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Cerebral ischemia and neuroregeneration
por: Lee, Reggie H. C., et al.
Publicado: (2018)

Can Any Drug Be Repurposed for Cancer Treatment? A Systematic Assessment of the Scientific Literature
por: Stransky, Nicolai, et al.
Publicado: (2021)

Repurposing cancer drugs to treat neurological diseases – Src inhibitors as examples
por: Liu, Da Zhi
Publicado: (2017)

Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives
por: Pawełczyk, Anna, et al.
Publicado: (2020)

Neuroprotection and Neuroregeneration in Alzheimer's Disease
por: Sugaya, Kiminobu, et al.
Publicado: (2012)

Artificial neural network and neuroregeneration
Publicado: (2012)

Acupuncture and neuroregeneration in ischemic stroke
por: Chang, Qwang-Yuen, et al.
Publicado: (2018)

Corrigendum: Cerebral ischemia and neuroregeneration
Publicado: (2022)

Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases
por: Guo, Deyin
Publicado: (2020)

Novel approaches for the development of peripheral nerve regenerative therapies
por: Beyer, Felix, et al.
Publicado: (2015)

Editorial: The molecular mechanisms and potential drug targets for remyelination and neuroregeneration
por: Rutkowska, Aleksandra, et al.
Publicado: (2023)

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
por: Rodrigues, Liliana, et al.
Publicado: (2022)

A Multi-Objective Approach for Anti-Osteosarcoma Cancer Agents Discovery through Drug Repurposing
por: Cabrera-Andrade, Alejandro, et al.
Publicado: (2020)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
por: Lythgoe, Mark P., et al.
Publicado: (2022)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs
por: Kast, Richard E., et al.
Publicado: (2021)

Human endogenous retroviruses: ammunition for myeloid cells in neurodegenerative diseases?
por: Gruchot, Joel, et al.
Publicado: (2019)

Editorial: Natural products for neuroprotection and neuroregeneration
por: Wong, Kah Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5bdqdld62ade11ijov8bkdslgq